Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Brought to you by

YM merges with Cytopia in $Cdn12mm deal

Oct 2009

Executive Summary

YM Biosciences (therapeutics for cancer and pain) has agreed to merge with Australia's Cytopia (oncology focused, with other treatments for cardiovascular, autoimmune, and inflammatory conditions). YM will issue one of its common shares for every 11.737 Cytopia shares, or an aggregate of 7.2mm shares valued at $Cdn12mm ($11.1mm). The per share ratio of $Cdn0.17 represents a 55% premium.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Includes Contract
    • Full Acquisition
    • Intra-Biotech Deal

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By